compon
therapi
neonat
isoerythrolysi
drug
therapi
current
drug
fluid
therapi
puppi
kitten
larg
base
inform
extrapol
speci
normal
matur
chang
puppi
kitten
birth
month
caus
accompani
chang
drug
disposit
thu
render
puppi
kitten
suscept
druginduc
advers
reaction
puppi
kitten
expos
drug
three
sourc
mother
either
parturit
placent
transfer
mother
milk
nurs
direct
administr
beyond
scope
paper
describ
factor
determin
drug
disposit
normal
healthi
adult
rivier
b
work
knowledg
factor
howev
crucial
predict
effect
ageinduc
differ
drug
disposit
appreci
differ
drug
fluid
therapi
individu
incid
advers
drug
reaction
reduc
young
anim
gener
advers
drug
reaction
reflect
plasma
drug
concentr
reach
toxic
rang
occasion
therapeut
failur
result
gener
plasma
concentr
subtherapeut
four
determin
drug
disposit
ie
absorpt
distribut
metabol
excret
undergo
dramat
chang
puppi
kitten
matur
clinic
signific
sequela
vari
tabl
oral
administr
drug
absorb
small
intestin
surfac
area
small
intestin
larg
even
young
anim
extent
drug
absorpt
probabl
differ
clinic
young
anim
adult
rate
drug
absorpt
tend
slower
young
anim
howev
probabl
due
decreas
gastric
empti
irregular
intestin
motil
result
peak
plasma
drug
concentr
may
lower
decreas
rate
absorpt
might
actual
protect
toxic
drug
concentr
heimann
rane
wilson
protect
mechan
may
howev
present
puppi
kitten
absorpt
colostrum
period
permeabl
intestin
mucosa
increas
along
rate
extent
drug
absorpt
occasion
drug
normal
absorb
gastrointestin
tract
aminoglycosid
carbenicillin
toxic
drug
distribut
fat
acidsensit
enter
sulfonamid
reach
system
circul
intestin
permeabl
decreas
rapidli
follow
ingest
colostrum
gillett
filkin
possibl
due
endogen
releas
hydrocortison
adrenocorticotrop
hormon
exogen
supplement
either
hormon
mother
hour
give
birth
prevent
increas
permeabl
colostrum
absorpt
neonat
gillett
filkin
number
factor
may
alter
drug
absorpt
small
intestin
puppi
kitten
gastric
ph
neutral
newborn
adult
level
reach
time
birth
depend
speci
gillett
filkin
heimann
increas
gastric
ph
achlorhydria
may
decreas
absorpt
mani
drug
requir
disintegr
dissolut
ioniz
less
acid
environ
eg
weak
acid
antimicrobi
gillett
filkin
rane
wilson
hand
increas
ph
may
facilit
absorpt
weak
base
gener
absorb
adult
anim
eg
aminoglycosid
milk
diet
reduc
absorpt
drug
either
decreas
gastric
empti
directli
interact
drug
unstir
water
layer
adjac
surfac
area
mucos
cell
thicker
neonat
older
anim
may
limit
rate
absorpt
drug
heimann
biliari
function
matur
absorpt
fatsolubl
drug
eg
griseofulvin
fatsolubl
vitamin
may
impair
microbi
colon
gastrointestin
tract
may
alter
respons
antimicrobi
drug
undergo
intestin
metabol
enterohepat
circul
jone
morselli
et
al
absorpt
puppi
kitten
parenter
administ
drug
also
vari
adult
rate
absorpt
intramuscular
administr
increas
age
muscl
mass
accompani
blood
flow
increas
vasomotor
respons
matur
morselli
et
al
muscl
mass
small
young
anim
subcutan
administr
frequent
use
variabl
subcutan
absorpt
rate
anticip
age
less
fat
water
may
result
faster
absorpt
puppi
kitten
compar
adult
environment
temperatur
probabl
influenc
subcutan
absorpt
particularli
newborn
whose
thermoregulatori
mechan
fulli
function
shifrin
et
ai
cold
environ
like
reduc
subcutan
drug
absorpt
neonat
provid
warmth
true
anim
state
hypothermia
subcutan
intramuscular
drug
absorpt
may
impair
bodi
temperatur
approxim
norm
sever
nontradit
rout
administr
use
puppi
kitten
intraperiton
administr
lifesav
method
blood
fluid
administr
particularli
newborn
inaccess
central
vein
isoton
fluid
solut
absorb
rapidli
red
blood
cell
absorb
within
hour
authement
et
ai
blood
fluid
solut
also
administ
medullari
caviti
larg
bone
authement
et
ai
fiser
flow
ratelimit
factor
intraoss
absorpt
factor
size
medullari
space
vascular
tortuos
sinusoid
pressur
total
venou
crosssect
area
determin
flow
rate
fiser
schoffstal
et
ai
absorpt
volatil
anesthet
agent
respiratori
tract
rapid
minut
ventil
greater
robinson
thu
young
anim
sensit
effect
ga
anesthet
agent
although
percutan
rout
commonli
use
drug
administr
percutan
absorpt
drug
like
greater
young
anim
percutan
absorpt
relat
directli
skin
hydrat
greatest
neonat
topic
administr
potenti
toxic
lipidsolubl
drug
eg
hexachlorophen
organophosph
avoid
absorpt
rectal
mucosa
rapid
age
thu
rectal
administr
drug
fluid
use
limit
data
gather
human
infant
indic
peak
plasma
concentr
rectal
administr
may
higher
obtain
rout
morselli
et
al
follow
situat
among
indic
rout
administr
venou
catheter
difficult
need
reduc
complic
associ
intraven
administr
sedat
anesthesia
oral
administr
undesir
antiemet
agent
sever
pediatr
drug
intend
system
effect
avail
rectal
suppositori
import
factor
contribut
differ
drug
distribut
puppi
kitten
differ
bodi
fluid
compart
bind
drug
serum
protein
bodi
fluid
compart
undergo
profound
chang
growth
neonat
percentag
total
bodi
water
ratio
compartment
volum
chang
matur
percentag
total
bodi
water
decreas
age
decreas
substanti
extracellular
intracellular
compart
tabl
sheng
huggin
daili
fluid
requir
greater
puppi
kitten
part
larger
proport
bodi
weight
repres
water
sequela
bodi
compart
differ
depend
normal
distribut
drug
watersolubl
drug
distribut
extracellular
fluid
result
puppi
kitten
volum
fluid
drug
distribut
increas
compar
adult
plasma
drug
concentr
decreas
correspondingli
similar
pattern
would
expect
unbound
lipidsolubl
drug
tend
di
tribut
total
bodi
water
chang
halflif
drug
parallel
chang
distribut
although
decreas
plasma
drug
concentr
result
increas
distribut
may
protect
young
anim
potenti
toxic
drug
concentr
davi
et
al
poor
therapeut
respons
may
result
failur
gener
therapeut
drug
concentr
proport
bodi
fat
smaller
puppi
kitten
thu
distribut
lipidsolubl
drug
accumul
fat
organophosph
chlorin
hydrocarbon
ultrashort
thiobarbitur
may
decreas
proportion
although
drug
halflif
decreas
volum
tissu
drug
distribut
plasma
drug
concentr
may
initi
toxic
mani
lipidsolubl
drug
high
affin
bound
plasma
protein
thu
facilit
movement
bodi
bind
howev
limit
distribut
plasma
tissu
predict
distribut
highli
proteinbound
drug
complic
serum
concentr
serum
albumin
protein
drug
bound
aglycoprotein
basic
drug
preferenti
bind
decreas
younger
anim
poffenbarg
et
al
short
protein
bind
drug
also
may
reduc
differ
albumin
structur
drug
compet
endogen
substrat
bilirubin
bind
site
ehrnebo
et
al
rane
wilson
drug
displac
concentr
free
pharmacolog
activ
drug
risk
advers
reaction
increas
howev
chang
signific
drug
highli
ie
protein
bound
character
small
therapeut
index
concentr
free
drug
increas
total
drug
plasma
tend
decreas
sinc
unbound
drug
free
distribut
tissu
ehrnebo
et
al
consequ
drug
halflif
may
increas
longer
dose
interv
may
indic
potenti
toxic
drug
differ
region
blood
flow
organ
might
caus
clinic
import
chang
drug
disposit
puppi
kitten
differ
intraorgan
distribut
eg
renal
blood
flow
may
caus
clinic
import
differ
drug
disposit
blood
flow
vesselrich
tissu
bodi
ie
heart
brain
greater
faster
robinson
puppi
kitten
thu
suscept
druginduc
cardiac
central
nervou
system
toxic
condit
potenti
central
nervou
system
poison
increas
bloodbrain
barrier
poorli
develop
immedi
birth
increas
permeabl
protect
mechan
brain
defici
nutrit
fuel
stress
state
eg
hypoglycemia
hypoxia
acidosi
prevent
allow
movement
oxidiz
substrat
lactat
brain
cell
hellmann
et
ai
drug
normal
incap
reach
adult
brain
also
howev
abl
reach
brain
cell
suscept
effect
drug
elimin
limit
puppi
kitten
green
mirkin
rane
wilson
short
contrast
infant
hepat
metabol
drug
incompet
nearterm
neonat
puppi
inman
yeari
reich
phase
eg
oxid
phase
ii
eg
glucuronid
reaction
reduc
variou
pathway
metabol
matur
differ
rate
progress
increas
phase
activ
occur
day
adult
level
attain
day
postpartum
gener
decreas
hepat
drug
metabol
reflect
decreas
plasma
clearanc
increas
plasma
halflif
potenti
toxic
plasma
drug
concentr
dose
reduct
prolong
interv
may
indic
drug
tabl
oral
bioavail
drug
character
signific
firstpass
metabol
adult
eg
propranolol
probabl
greater
puppi
kitten
respons
prodrugssuch
primidon
prednison
potenti
methylprednisolonemay
reduc
decreas
format
activ
drug
product
hepat
drugmetabol
enzym
induc
phenobarbit
drug
peter
et
al
rane
wilson
phenobarbit
use
therapeut
stimul
drug
elimin
fetal
neonat
human
infant
sjoqvist
nonhepat
drug
metabol
also
tend
defici
puppi
kitten
import
elimin
drug
lower
plasma
cholinesteras
level
result
increas
sensit
organophosph
succinylcholin
procain
robinson
reduc
renal
excret
characterist
puppi
result
decreas
clearanc
renal
caffein
theophyllinej
nonsteroid
antiinflammatori
drug
j
opiat
phenothiazin
j
chlorpromazin
salicyl
j
bodi
fluid
electrolyt
maintain
kleinman
silva
et
al
sequela
development
chang
pediatr
renal
function
includ
decreas
clearanc
prolong
halflif
drug
primarili
watersolubl
drug
excret
kidney
pattern
shown
sever
drug
tabl
effect
renal
matur
drug
disposit
complex
exampl
serum
gentamicin
halflif
twice
long
puppi
minut
puppi
minut
tubular
damag
howev
begin
occur
day
age
despit
tubular
accumul
gentamicin
excret
parent
drug
product
phase
ii
drug
metabol
glomerular
filtrat
rate
tubular
secret
increas
sevenfold
fourfold
respect
day
day
puppi
increas
presum
reflect
increas
permeabl
filtrat
apparatu
human
infant
renal
clearanc
weight
dextran
essenti
zero
compar
clearanc
adult
dorrestein
et
ai
chang
renal
blood
flow
parallel
nephron
matur
cowan
et
ai
although
number
glomeruli
remain
constant
throughout
develop
glomerular
filtrat
renal
tubular
function
progress
increas
cowan
et
al
distribut
matur
nephron
also
chang
age
puppi
morpholog
renal
matur
follow
centrifug
pattern
matur
nephron
locat
corticomedullari
junction
youngest
subcapsular
layer
neither
renal
blood
flow
glomerular
filtrat
rate
increas
appreci
blood
flow
redistribut
cortic
week
age
cowan
et
al
kidney
matur
puppi
rate
tubular
growth
appear
exceed
glomerular
growth
glomerulartubular
balanc
sodium
water
poorli
develop
neonat
contrast
filtrat
secret
renal
tubular
resorpt
appear
similar
adult
long
similar
adult
site
accumul
primarili
inner
cortex
first
day
life
outer
cortex
cortic
nephron
matur
centrifug
pattern
nephron
matur
puppi
appear
protect
gentamicin
nephrotox
ensur
outer
cortic
nephron
probabl
protect
damag
matur
anoth
differ
aminoglycosid
toxic
puppi
kitten
lack
clinic
indic
patholog
damag
induc
gentamicin
appear
evidenc
sole
histolog
lesion
plasma
creatinin
normal
decreas
pediatr
individu
cowan
et
ai
thu
increas
normal
presenc
gentamicin
nephrotox
chang
urin
sediment
osmolar
glucos
protein
evid
even
tubular
damag
mark
day
cowan
et
al
renal
damag
occur
puppi
kitten
treat
gentamicin
trough
concentr
jlgml
well
recommend
avoid
nephrotox
ugml
fact
observ
peak
plasma
gentamicin
concentr
ugml
much
lower
young
anim
dose
mgkg
daili
compar
recommend
target
jlg
ml
gener
achiev
adult
dog
lower
dose
mglkg
daili
suggest
differ
dose
regimen
use
aminoglycosid
compar
current
recommend
adult
puppi
may
requir
higher
dose
longer
interv
gentamicin
administr
gentamicindos
regimen
unhealthi
puppi
probabl
modifi
like
suffer
condit
increas
potenti
aminoglycosidesinduc
nephrotox
eg
dehydr
investig
need
establish
safe
yet
effect
dose
aminoglycosid
puppi
kitten
uniqu
differ
drug
disposit
predispos
nearterm
fetu
neonat
advers
drug
reaction
idea
absolut
placent
select
replac
realiz
essenti
drug
administ
pregnant
anim
transfer
across
placenta
regardless
degre
intimaci
fetal
placent
membran
levi
welsch
respons
fetu
newborn
individu
drug
howev
vari
sever
reason
even
simplest
pharmacokinet
represent
maternalfet
system
complex
compos
least
three
compart
matern
placent
fetal
pharmacokinet
compart
determin
tum
rate
absorpt
distribut
metabol
elimin
krauer
krauer
welsch
furthermor
pregnanc
dynam
state
character
dramat
chang
placent
fetal
growth
physiolog
pregnant
anim
pharmacokinet
process
chang
concert
progress
pregnanc
addit
specif
differ
placent
drug
transfer
preclud
extrapol
inform
among
speci
final
rout
administr
also
like
determin
amount
placent
transfer
rout
result
higher
plasma
peak
concentr
ie
intraven
intraven
infus
multipl
dose
rout
like
expos
fetu
higher
drug
concentr
although
mani
factor
determin
rate
extent
drug
transfer
across
placenta
lipid
solubl
drug
steep
maternalfet
drug
concentr
gradient
probabl
import
welsch
gener
nonion
compound
high
lipid
solubl
cross
rapidli
wherea
drug
littl
lipid
solubl
cross
slowli
malkinson
gehlmann
number
drug
polar
physiolog
ph
howev
cross
placenta
rapidli
differ
drug
disposit
compar
pediatr
anim
adult
lead
advers
reaction
nearterm
fetu
receiv
drug
placenta
thu
higher
concentr
unbound
pharmacolog
activ
drug
anticip
fetal
protein
gener
less
matur
anim
anatom
peculiar
fetal
circulationthat
bypass
fetal
liver
lungsresult
higher
concentr
drug
reach
heart
brain
although
fetal
metabol
drug
contribut
ultim
elimin
drug
human
neonat
amount
drugmetabol
enzym
present
nearterm
anim
neglig
malkinson
gehlmann
exampl
drug
shown
reach
detect
potenti
clinic
import
concentr
human
fetu
includ
antimicrobi
agent
salicyl
nonsteroid
antiinflammatori
drug
anticonvuls
phenytoin
diazepam
local
anesthet
lidocain
gentamicin
speci
narcot
analges
agent
although
drug
administ
pregnant
ani
aminoglycosid
anticanc
drug
chloramphenicol
tetracyclin
dosag
mglkg
given
three
time
daili
nara
et
al
chang
white
blood
cell
includ
basophil
granul
chloramphenicol
howev
appear
affect
vitro
vivo
immun
respons
nara
et
al
puppi
kitten
suscept
hemolyt
anemia
administr
drug
capabl
oxid
hemoglobin
gross
et
al
red
blood
cell
predispos
methemoglobinemia
heinz
bodi
format
vitro
hemolysi
sever
mechan
propos
includ
decreas
intracellular
concentr
antioxid
radic
scaveng
necrot
enterocol
complic
oral
administ
solut
see
enter
hyperaliment
later
intraven
administ
hyperton
solut
eg
sodium
bicarbon
clinic
sign
reflect
gastric
distent
gastrointestin
hemorrhag
vomitu
may
bile
stain
intestin
perfor
sequela
puppi
kitten
accommod
larg
shift
osmol
well
adult
administr
hyperton
solut
young
anim
result
varieti
advers
effect
intraventricular
hemorrhag
necrot
enterocol
occur
intraven
administr
sodium
bicarbon
radiocontrast
materi
arant
gooch
turbervil
et
al
drug
addit
contribut
significantli
osmol
intraven
prepar
ernst
et
al
hyperosmolar
also
sequela
oral
drug
fluid
administr
fetu
nurs
anim
inadvert
recipi
drug
administ
mother
pertin
inform
veterinari
literatur
concern
excret
drug
milk
food
anim
appear
inform
small
anim
studi
human
indic
drug
diffus
milk
matern
circul
low
molecular
weight
less
nonion
highli
lipidsolubl
drug
minim
protein
bound
diffus
lactat
mammari
gland
rapidli
wherea
watersolubl
drug
diffus
slowli
berlin
pi
drug
larg
determin
concentr
milk
anim
milk
tend
acid
compar
plasma
ph
thu
although
weakli
basic
drug
may
nonion
plasma
thu
like
diffus
milk
may
becom
ioniz
nondiffus
milk
ion
trap
concentr
drug
milk
ratio
drug
milk
drug
plasma
predict
greater
weak
base
weak
acid
whose
pk
differ
ph
milk
ph
unit
minu
acid
plu
base
rasmussen
gener
amount
drug
excret
milk
less
matern
dose
berlin
greater
concentr
howev
expect
drug
administ
mother
intraven
intraven
infus
multipl
dose
drug
ingest
milk
nurs
absorb
gastrointestin
tract
nurs
anim
exampl
milk
may
decreas
absorpt
drug
pharmacokinet
properti
drug
ie
aminoglycosid
preclud
absorpt
except
young
drug
must
howev
absorb
caus
clinic
import
advers
effect
exampl
antimicrobi
agent
potenti
alter
develop
flora
puppi
kitten
alimentari
tract
jone
smith
thu
prudent
avoid
administr
potenti
toxic
drug
lactat
mother
tabl
mal
may
detect
fetu
may
produc
clinic
import
effect
hematolog
chang
polychromasia
anisocytosi
target
cell
occur
puppi
treat
chloramphenicol
jst
pharmacokinet
differ
drug
disposit
lead
advers
drug
reaction
due
increas
decreas
plasma
drug
concentr
puppi
kitten
pharmacodynam
differ
result
toxic
subtherapeut
respons
particularli
cardiovascular
system
cardiovascular
respons
anticholinerg
inotrop
drug
like
attenu
neonat
exampl
increas
heart
rate
administr
drug
isoproterenol
dopamin
dobutamin
reach
adult
level
week
age
driscol
et
al
poffenbarg
et
al
immatur
innerv
cite
caus
decreas
respons
atropin
robinson
differ
compon
immun
system
matur
variou
age
poffenbarg
et
ai
shifrin
et
ai
thymu
undergo
increas
size
first
week
life
puppi
probabl
major
determin
immunocompet
although
humor
respons
evid
birth
igm
produc
neonat
puppi
gener
respond
poorli
strong
antigen
shifrin
et
ai
thu
although
puppi
kitten
expect
develop
drug
allergi
respons
immunomodul
attenu
addit
immunoincompet
necessit
use
bactericid
drug
puppi
kitten
predispos
dehydr
extracellular
fluid
increas
renal
capac
conserv
water
decreas
ratio
surfac
area
bodi
weight
larg
fluid
loss
immatur
skin
greater
kerner
sunshin
brain
volum
normal
decreas
first
day
life
puppi
kitten
hypovolem
hypotens
age
predispos
neonat
intracrani
hemorrhag
particularli
follow
rapid
volum
replac
coulter
et
ai
turbervil
et
al
hyperosmolar
increas
risk
intracrani
hemorrhag
due
water
loss
brain
arant
gooch
coulter
et
ai
turbervil
et
ai
fluid
requir
greater
puppi
kitten
adult
rate
recommend
daili
mainten
vari
ml
kgday
mosier
puppi
kitten
accommod
volum
overload
effici
adult
although
larger
fluid
amount
indic
care
must
taken
amount
rate
fluid
administr
fluid
administ
sever
rout
crystalloid
administ
rectal
isoton
rapid
rectal
absorpt
hyperosmot
solut
lead
lifethreaten
hyperosmolar
subcutan
administr
may
accept
rout
small
volum
isoton
fluid
administ
puppi
kitten
normal
hydrat
despit
less
ideal
flow
rate
intraoss
drug
fluid
infus
lifesav
hypovolem
hypotherm
small
anim
whose
central
vein
initi
access
catheter
fiser
schoffstal
et
al
femur
humeru
prefer
site
hypoderm
needl
spinal
needl
use
intraoss
cathet
depend
size
anim
otto
et
al
larger
anim
second
cathet
place
second
medullari
caviti
facilit
rapid
fluid
administr
graviti
flow
use
smaller
anim
larger
anim
multipl
cathet
pressureassist
flow
may
necessari
administ
suffici
volum
rapidli
otto
et
al
potenti
complic
uncommon
human
patient
includ
infect
result
cellul
subcutan
abscess
osteomyel
extravas
fluid
around
punctur
site
factor
contribut
therapeut
failur
intraoss
administr
includ
misplac
needl
cathet
bend
needl
clot
content
punctur
throughout
bone
replac
marrow
caviti
fat
fibrou
tissu
fiser
schoffstal
et
ai
intraven
administr
via
indwel
cephal
jugular
cathet
prefer
continu
fluid
drug
administr
dehydr
hypovolem
hypotens
anim
fluid
accur
measur
administr
pediatr
minidrip
set
design
deliv
drop
per
ml
use
infus
pump
facilit
accur
administr
fluid
administ
surgic
pediatr
anim
weigh
less
kg
rate
mlkg
per
hour
fluid
lost
surgeri
ad
volum
robinson
hypoglycemia
prevent
administr
dextros
solut
dextros
normal
salin
solut
robinson
altern
dextros
suffici
make
mgml
solut
ad
lactat
ringer
solut
although
result
hyperton
solut
administ
cautious
fluid
solut
blood
blood
compon
warm
administr
monitor
fluid
therapi
critic
overhydr
lead
cardiovascular
overload
sign
vascular
overload
difficult
detect
cardiomegali
hepat
enlarg
pulmonari
edema
gener
conspicu
respiratori
distress
occur
human
infant
volum
overload
lead
congest
heart
failur
associ
open
ductu
arteriosu
intracrani
hemorrhag
row
et
ai
textur
bodi
skin
moist
mucou
membran
degre
anophthalmia
rel
insensit
method
use
assess
hydrat
statu
puppi
kitten
serial
measur
urinari
output
urin
concentr
use
assess
fluid
therapi
human
infant
row
et
al
weigh
anim
everi
hour
also
help
establish
hydrat
statu
accur
gram
scale
avail
gener
puppi
kitten
gain
g
pound
anticip
adult
weight
per
day
mosier
oral
rehydr
recommend
prefer
therapi
dehydr
caus
diarrhea
human
pediatr
patient
greenwood
davison
hirschhorn
sodium
cotransport
sever
substrat
activ
transport
across
epithelium
small
intestin
oral
administr
sodium
potassium
bicarbon
chlorid
glucos
singl
solut
sole
method
hydrat
need
maintain
normal
blood
volum
electrolyt
concentr
human
patient
cholera
world
health
organ
formul
solut
consist
mm
per
liter
na
k
ci
glucos
total
osmolar
hirschhorn
solut
suitabl
case
diarrhea
human
patient
regardless
caus
electrolyt
statu
hydrat
statu
short
shock
patient
age
requir
patient
suffici
consciou
drink
vomit
occur
patient
allow
rest
administr
reinstitut
slowli
recent
modif
recip
includ
addit
organ
nonelectrolyt
amino
acid
particularli
secretori
diarrhea
wapnir
et
al
wapnir
et
al
nutrit
mainten
critic
puppi
kitten
studi
perform
newborn
puppi
shown
fast
accompani
reduc
hepat
adenosin
level
suggest
endogen
fuel
capabl
maintain
hepat
energi
product
fast
oxidiz
energi
store
deplet
total
bodi
metabol
decreas
kliegrnan
morton
drug
end
blood
compon
thllrepi
fuel
avail
cerebr
metabol
restrict
kliegrnan
et
ai
cerebr
hypoglycemia
consid
along
hypoxia
seizur
acidosi
major
metabol
stress
lead
loss
autoregul
cerebr
blood
flow
anwar
vannucci
although
parenter
hyperaliment
welldescrib
therapeut
mean
maintain
nutrit
adult
dog
cat
littl
inform
avail
regard
applic
puppi
kitten
pediatr
human
requir
calorieskg
per
day
kerner
sunshin
studi
human
howev
shown
weight
gain
calorieskg
per
day
provid
form
glucos
amino
acid
lipid
infus
kerner
sunshin
calor
requir
puppi
kitten
increas
age
rang
kcallkg
week
kcallkg
week
mosier
glucos
intoler
occur
neonat
infus
dextros
solut
hyperglycemia
result
osmot
diuresi
electrolyt
loss
human
infant
infus
rate
mglkg
per
minut
exceed
particularli
lowbirthweight
infant
kerner
sunshin
rebound
hypoglycemia
occur
glucos
infus
stop
suddenli
infus
reiniti
soon
possibl
infant
develop
toler
glucos
amino
acid
ad
recommend
amount
enter
amino
acid
supplement
optim
growth
human
infant
glkg
per
day
parenter
dose
glkg
per
day
well
toler
free
amino
acid
prefer
casein
hydrolys
gener
infus
solut
ernst
et
ai
glucos
infus
amino
acid
infus
initi
low
concentr
l
gradual
increas
patient
develop
toler
gkg
per
day
ernst
et
al
optim
amino
acid
mixtur
vari
age
human
pediatr
patient
like
similar
variat
exist
puppi
kitten
hepat
enzym
matur
hyperchloremia
metabol
acidosi
recogn
possibl
complic
amino
acid
infus
human
pediatr
patient
particularli
synthet
prepar
administ
although
infus
fat
emuls
appear
safe
human
infant
decreas
toler
may
occur
prematur
infant
evidenc
increas
serum
triglycerid
free
fatti
acid
term
infant
toler
infus
much
better
rate
infus
surpass
clearanc
howev
potenti
complic
includ
alter
pulmonari
function
overload
character
hyperlipemia
fever
lethargi
liver
damag
coagulopathi
visual
inspect
plasma
turbid
measur
serum
triglycerid
use
monitor
develop
overload
ernst
et
al
mainten
sodium
potassium
human
infant
requir
meqkg
per
day
ernst
et
al
requir
may
even
greater
neonat
daili
requir
calcium
phosphoru
magnesium
kg
basi
meq
meq
respect
vitamin
gener
supplement
administr
ml
multivitamin
infus
product
addit
folat
ug
vitamin
b
ug
vitamin
k
mg
ernst
et
al
total
parenter
nutrit
must
monitor
close
evalu
serum
chemistri
help
determin
success
meet
metabol
need
ernst
et
al
growth
anim
evalu
weight
human
measur
subcutan
fat
muscl
mass
made
aid
calip
skinfold
thick
indirect
indic
calor
protein
reserv
ernst
et
al
advers
effect
may
limit
use
enter
hyperaliment
puppi
kitten
necrot
enterocol
common
complic
alimentari
infus
solut
human
infant
direct
mucos
irrit
hyperton
solut
cite
primari
caus
formula
administ
puppi
howev
result
hyperton
intestin
content
regardless
tonic
infus
goldblum
et
ai
delay
gastric
empti
interfer
absorpt
nutrient
may
also
contribut
pathophysiolog
although
caus
necrot
enterocol
clear
administr
hyperton
solut
avoid
neonat
adult
appreci
chemotherapeut
triangl
ie
relationship
host
drug
microorgan
necessari
appropri
use
antimicrobi
agent
puppi
kitten
sever
antimicrobi
agent
avoid
use
chloramphenicol
neonat
discuss
earlier
addit
effect
hematopoiet
system
chloramphenicol
caus
acut
myocardi
depress
human
gray
babi
syndrom
possibl
due
inhibit
protein
synthesi
mitochondri
oxid
werner
et
ai
chloramphenicol
avoid
puppi
kitten
although
tetracyclin
may
overtli
toxic
puppi
kitten
chelat
calcium
grow
bone
inhibit
growth
caus
deform
chelat
teeth
result
enamel
dysplasia
discolor
major
consider
puppi
kitten
receiv
oral
antimicrobi
agent
effect
colon
alimentari
tract
ion
tetracyclin
particularli
doxycyclin
drug
undergo
enterohepat
circul
like
disrupt
normal
colon
alimentari
tract
antimicrobi
agent
gener
drug
choic
puppi
kitten
whenev
possibl
although
halfliv
like
prolong
drug
tend
safe
character
wide
therapeut
index
higher
dose
may
necessari
achiev
desir
peak
plasma
drug
concentr
distribut
greater
time
interv
administr
prolong
compens
longer
halflif
parenter
absorpt
prefer
bioavail
oral
prepar
predict
caution
indic
use
high
dose
antimicrobi
agent
caus
bleed
tendenc
anim
risk
factor
bleed
babiak
rybak
although
undocu
bleed
tendenc
note
puppi
receiv
antimicrobi
agent
caution
indic
administ
drug
particularli
high
dose
young
risk
give
aminoglycosid
puppi
kitten
may
outweigh
benefit
drug
inform
necessari
appropri
dose
regimen
age
group
simpli
avail
therapeut
drug
monitor
use
possibl
guid
therapi
higher
dose
longer
interv
may
necessari
achiev
recommend
peak
trough
concentr
amikacin
less
nephrotox
effect
pseudomona
speci
gentamicin
use
whenev
possibl
quinolon
effect
anim
safe
antimicrobi
agent
character
excel
tissu
distribut
drug
howev
avoid
largeto
giantbre
puppi
younger
month
destruct
lesion
cartilag
long
bone
thu
author
recommend
drug
first
choic
puppi
kitten
combin
sulfonamid
trimethoprim
ormetoprim
tend
safe
effect
puppi
kitten
dose
may
howev
need
reduc
neonat
puppi
halflif
sulfonamid
prolong
age
group
inman
yeari
potenti
sulfonamid
avoid
anim
anemia
therapeut
indic
lincosamid
macrolid
limit
puppi
kitten
group
drug
undergo
extens
biliari
secret
enterohepat
circul
use
firstchoic
antimicrobi
agent
except
made
mycoplasma
infect
tylosin
drug
choic
metronidazol
drug
choic
treatment
anaerob
infect
decreas
clearanc
prolong
halflif
anticip
puppi
kitten
lower
dose
longer
interv
may
necessari
avoid
central
nervou
system
toxic
transfus
blood
compon
frequent
necess
adjunct
treatment
puppi
kitten
blood
compon
commonli
use
fresh
whole
blood
pack
red
blood
cell
plasma
authement
et
al
buchel
cotter
indic
fresh
whole
blood
hemorrhag
shock
ongo
bleed
simultan
loss
red
cell
plasma
anemia
requir
erythrocyt
may
treat
transfus
pack
red
cell
cotter
bleed
disord
secondari
congenit
coagulopathi
treat
plasma
transfus
veterinarian
also
believ
hypoproteinem
septic
puppi
kitten
colostrum
depriv
benefit
plasma
infus
kg
age
optim
year
donor
cat
must
kept
strictli
indoor
risk
viral
infect
cat
pcv
donor
blood
type
type
blood
see
tabl
simpl
blood
type
kit
dog
cat
commerci
avail
blood
donor
period
examin
eg
complet
blood
count
serum
chemistri
profil
urinalys
fecal
examin
donor
dog
serolog
neg
dirofilaria
immiti
ehrlichia
speci
rocki
mountain
spot
fever
lyme
diseas
blood
group
antigen
capabl
stimul
format
specif
antibodi
howev
antigen
greatest
potenti
antigen
stimul
cat
natur
occur
antibodi
render
suscept
transfus
reaction
even
first
one
dea
dog
erythrocyt
antigen
donor
dog
usual
larg
dog
pack
cell
volum
pcv
medic
except
heartwormprevent
fleatickprevent
medic
heartworminfest
flea
tickinfest
area
sensit
prior
transfus
pregnanc
cotter
pichler
turnwald
donor
blood
type
neg
dog
erythrocyt
antigen
dea
loci
tabl
unless
recipi
type
well
bull
dodd
authement
et
ai
cotter
pichler
turnwald
donor
cat
serolog
neg
toxoplasma
gondii
haemobartonella
feli
via
polymeras
chain
reaction
ebrlichia
speci
dirofilariasi
felin
coronaviru
titer
risk
felin
infecti
periton
felin
leukemia
viru
infect
felin
immunodefici
viru
infect
buchel
cotter
cotter
pichler
turnwald
donor
well
vaccin
maintain
good
nutrit
feed
program
kept
free
flea
tick
intestin
parasit
particularli
hookworm
giardia
cryptosporidium
speci
variou
site
avail
draw
blood
dog
cat
donor
safest
access
site
blood
collect
extern
jugular
vein
amount
blood
safe
withdrawn
via
extern
jugular
vein
donor
dog
cat
mlkg
millb
bodi
weight
everi
week
authement
et
ai
green
potkay
zinn
usual
amount
approxim
ml
blood
taken
larg
canin
donor
ml
taken
cat
donor
may
minim
restrain
sedat
cotter
venipunctur
site
surgic
prepar
hemostat
place
tube
plastic
bloodcollect
bag
remov
extern
jugular
vein
enter
venipunctur
clean
rapid
blood
flow
minim
activ
platelet
clot
factor
minim
tissu
thromboplastin
contamin
authement
et
ai
full
blood
volum
collect
collect
tube
reclamp
needl
remov
extern
jugular
vein
direct
pressur
appli
collect
site
minut
collect
blood
hemostasi
cat
appear
pale
blood
collect
probabl
result
combin
hypovolemia
sedat
cotter
reason
intraven
infus
ml
lactat
ringer
solut
given
donor
cat
immedi
blood
drawn
buchel
cotter
infus
usual
necessari
donor
dog
blood
collect
anticoagul
citratephosphateadenin
cpoai
solut
less
prefer
acidcitratedextros
aco
solut
authement
et
ai
pichler
turnwald
ratio
volum
cpoai
aco
anticoagul
blood
storag
blood
compon
canin
blood
cpoai
storag
life
day
versu
day
acd
c
authement
et
ai
buchel
cotter
green
smith
et
ai
blood
given
immedi
collect
dilut
ratio
anticoagul
blood
use
heparin
use
unit
use
per
ml
blood
collect
authement
et
al
citrat
prefer
citrat
metabol
quickli
platelet
function
preserv
heparin
recommend
anticoagul
red
blood
cell
store
platelet
function
abnorm
procedur
whole
blood
collect
cpoa
acd
plastic
bloodcollect
bag
appropri
volum
swirl
blood
collect
ensur
adequ
mix
anticoagul
monitor
volum
blood
withdrawn
tripl
beam
balanc
scale
digit
electron
scale
may
use
one
millilit
blood
weigh
approxim
g
unit
contain
ml
blood
weigh
g
plu
weight
contain
anticoagul
widmann
collect
collect
tube
tie
needl
end
blood
left
tube
strip
use
tube
stripper
twice
allow
collect
blood
mix
anticoagul
collect
bag
unit
collect
blood
use
immedi
store
appropri
temperatur
later
use
small
volum
whole
blood
need
immedi
use
ml
cpoai
aco
anticoagul
may
drawn
plastic
syring
rest
fill
blood
cotter
open
system
plastic
syring
bag
enter
needl
use
within
hour
whole
blood
collect
one
proceed
separ
fresh
whole
blood
pack
red
cell
plasma
best
way
blood
compon
avail
veterinari
practic
work
cooper
local
human
blood
bank
facil
blood
collect
plastic
bloodcollect
bag
cpoai
aco
anticoagul
transport
directli
local
blood
bank
facil
icefil
cooler
blood
allow
come
contact
ice
authement
et
al
blood
bank
facil
bloodfil
cpoai
acd
bag
centrifug
centrifug
speed
rpm
g
minut
methodolog
vari
protocol
use
local
blood
bank
centrifug
extract
plasma
transfer
satellit
storag
contain
red
blood
cell
remain
extract
plasma
label
pack
red
blood
cell
store
later
use
clinician
freez
plasma
individu
box
avail
local
blood
bank
plastic
bloodcollect
bag
fragil
cold
temperatur
may
crack
manipul
authement
et
al
freshfrozen
plasma
plasma
frozen
within
hour
time
blood
collect
use
primarili
suppli
clot
factor
treatment
hemophilia
von
willebrand
diseas
rodenticid
toxic
dissemin
intravascular
coagul
frozen
store
optim
preserv
clot
factor
year
household
freezer
month
frozen
plasma
plasma
frozen
hour
time
collect
freshfrozen
plasma
older
year
use
suppli
labil
factor
treatment
hemophilia
von
willebrand
diseas
dissemin
intravascular
coagul
although
use
treatment
hemophilia
b
factor
ix
requir
rodenticid
toxic
factor
ii
vii
ix
x
requir
shelf
life
year
store
similar
manner
freshfrozen
plasma
best
altern
type
blood
inhous
donor
recipi
anim
crossmatch
donor
recipi
blood
dodd
incompat
reveal
crossmatch
indic
earlier
sensit
recipi
natur
occur
isoantibodi
puppi
kitten
need
repeat
transfus
given
blood
donor
bloodtyp
crossmatch
compat
crossmatch
perform
major
minor
compat
major
crossmatch
perform
donor
cell
recipi
serum
determin
whether
recipi
antibodi
donor
cell
minor
crossmatch
use
recipi
cell
donor
serum
detect
antibodi
donor
serum
recipi
cell
test
perform
fresh
blood
blood
sampl
approxim
ml
collect
donor
recipi
anim
drug
blood
compon
therapi
allow
clot
centrifug
serum
withdrawn
place
separ
tube
clot
gentli
broken
oj
ml
cell
aspir
sampl
ad
separ
tube
contain
ml
normal
salin
solut
altern
one
collect
ml
blood
ethylenediamin
tetraacet
acid
tube
separ
red
cell
centrifug
cell
wash
least
normal
salin
solut
remov
plasma
prevent
format
small
fibrin
clot
widmann
cell
wash
supernat
fluid
discard
cell
resuspend
dilut
ml
cell
ml
normal
salin
solut
major
crossmatch
perform
ad
ml
recipi
serum
ml
donor
red
cell
suspens
minor
crossmatch
perform
ad
ml
donor
serum
ml
recipi
red
cell
suspens
control
reaction
test
perform
use
recipi
serum
wash
cell
optim
test
done
triplic
incub
minuteson
set
one
set
room
temperatur
one
set
incub
variou
temperatur
may
benefici
incompat
reaction
occur
rang
temperatur
canin
blood
group
antibodi
often
hemolyt
agglutin
clinician
believ
benefici
add
drop
rabbit
complement
crossmatch
tube
incub
tube
centrifug
minut
g
supernat
fluid
examin
hemolysi
tube
gentli
tap
check
agglutin
compat
crossmatch
show
agglutin
hemolysi
overt
agglutin
note
small
amount
suspend
materi
transfer
clean
glass
slide
microscop
examin
low
power
degre
agglutin
hemolysi
major
crossmatch
consid
evid
incompat
indic
transfus
perform
slight
agglutin
hemolysi
detect
minor
crossmatch
transfus
perform
emerg
basi
store
blood
compon
warm
room
temperatur
administr
prevent
induc
hypothermia
recipi
warm
blood
compon
pass
coil
transfus
tube
immers
water
bath
maintain
altern
blood
compon
contain
place
water
bath
dri
incub
maintain
temperatur
frozen
plasma
warm
slowli
microwav
oven
dula
et
al
hurst
et
al
excess
heat
use
acceler
warm
blood
compon
fibrinogen
precipit
autoagglutin
occur
temperatur
exceed
blood
compon
contain
open
enter
needl
warm
content
given
within
hour
reduc
possibl
bacteri
growth
cotter
warm
blood
compon
return
storag
microwav
thaw
frozen
plasma
plasma
contain
place
water
bath
second
hurst
et
ai
plasma
contain
dri
towel
enclos
outer
plastic
bag
place
center
microwav
oven
oven
set
highest
set
w
plasma
contain
irradi
microwav
interv
second
exposur
microwav
plasma
contain
agit
hand
approxim
second
procedur
continu
singl
piec
ice
less
em
long
remain
contain
remov
microwav
oven
invert
sever
time
frozen
particl
remain
approxim
second
appropri
filter
administr
set
use
blood
compon
transfus
filter
design
retain
blood
clot
leukocyteplatelet
aggreg
pulmonari
microembol
potenti
complic
transfus
blood
compon
authement
et
al
transfus
blood
compon
requir
filter
blood
syring
also
given
standard
blood
transfus
set
infus
set
sidearm
luer
connector
syring
blood
compon
given
intraven
larg
dog
cephal
extern
jugular
vein
indwel
cathet
smaller
dog
larg
cat
infus
cephal
extern
jugular
vein
indwel
cathet
young
puppi
kitten
transfus
cephal
extern
jugular
vein
infus
set
reduc
viscos
smallbor
needl
use
blood
compon
mix
normal
salin
solut
infus
use
fluid
solut
normal
salin
recommend
green
hypotherm
dehydr
puppi
kitten
younger
month
venipunctur
often
imposs
transfus
intraoss
rout
consid
better
intraperiton
rout
blood
compon
may
given
intramedullari
space
femur
humeru
spinal
needl
appropri
needl
size
length
vari
size
age
anim
transfus
spinal
needl
insert
asept
parallel
long
axi
bone
trochanter
fossa
femur
greater
tubercl
humeru
respect
medullari
space
fig
stylet
within
needl
withdrawn
immedi
infus
blood
compon
absorpt
infus
blood
compon
rapid
clark
woodley
corley
spinal
needl
within
intramedullari
space
remov
infus
left
place
hour
need
intraperiton
rout
result
approxim
absorpt
blood
compon
system
circul
within
hour
within
hour
clark
woodley
ineffici
rate
absorpt
intraperiton
rout
discourag
infus
blood
compon
baselin
valu
variabl
bodi
weight
temperatur
puls
respiratori
rate
mucou
membran
color
pci
total
plasma
protein
concentr
obtain
recipi
slow
infus
rate
mllkg
bodi
weight
use
period
recipi
watch
care
transfus
reaction
slow
initi
infus
rate
minim
amount
incompat
blood
compon
administ
event
recipi
display
immedi
reaction
recipi
problem
initi
period
rate
infus
increas
transfus
one
check
blood
sampl
pcv
increas
possibl
presenc
hemoglobinemia
recommend
infus
rate
whole
blood
dog
cat
mllkg
per
day
green
guidelin
flexibl
infus
rate
depend
physic
condit
hydrat
statu
recipi
hypovolem
recipi
mllkg
per
hour
accept
green
circulatori
overload
continu
problem
normovolem
recipi
may
compound
recipi
cardiac
renal
failur
evidenc
urticaria
cough
vomit
promin
jugular
vein
sign
pulmonari
edema
dog
cat
cardiac
failur
may
toler
infus
rate
exceed
mllkg
per
hour
therefor
requir
care
monitor
central
venou
pressur
authement
et
ai
green
circulatori
overload
also
induc
easili
transfus
anem
cat
especiallyyoung
kitten
cotter
amount
whole
blood
necessari
infus
estim
use
donor
recipi
hematocrit
recipi
bodi
weight
kilogram
follow
green
ml
donor
hlood
anticoagul
x
recipi
weight
kg
x
dog
cat
x
hematocrit
desir
minu
hematocrit
recipi
hematocrit
donor
blood
anticoagul
altern
simpl
guidelin
mil
kg
whole
blood
mllkg
pack
red
cell
rais
pcv
pcv
transfus
blood
green
pack
red
blood
cell
pcv
infus
recipi
manner
whole
blood
masouredi
disadvantag
use
slower
infus
rate
problem
larg
volum
blood
must
infus
rapid
rate
slower
rate
infus
overcom
dilut
pack
red
iood
cell
winorm
salin
solut
immedi
infus
dilut
requir
normal
salin
soludrug
blood
compon
therapi
tion
ad
ratio
ml
salin
solut
ml
pack
red
blood
cell
amount
normal
salin
solut
ad
infus
vari
recipi
circulatori
function
hydrat
statu
cotter
fresh
plasma
freshfrozen
plasma
frozen
plasma
administ
activ
bleed
owe
clot
factor
defici
sugget
dose
mlkg
bodi
weight
time
day
day
bleed
control
authement
et
ai
dodd
although
complic
blood
compon
transfus
rel
rare
puppi
kitten
occur
hemolyt
reaction
result
incompat
red
blood
cell
given
recipi
develop
antibodi
prior
sensit
transfus
type
b
cat
gener
strong
preform
antia
antibodi
react
hemolysi
first
transfus
cotter
buchel
hemolyt
reaction
dog
delay
evid
shorter
red
blood
cell
surviv
transfus
develop
posit
result
direct
coomb
test
tangner
reaction
prevent
blood
type
donor
dog
use
donor
neg
dea
dea
perform
crossmatch
recipi
receiv
prior
transfus
authement
et
ai
hemolysi
also
occur
result
overh
freez
blood
compon
concurr
administr
hypoton
solut
mechan
damag
red
blood
cell
caus
use
faulti
equip
collect
storag
administr
infus
pressur
smallbor
needl
cathet
plug
filter
cotter
advers
effect
leukocyt
platelet
plasma
protein
incompat
includ
fever
neurolog
sign
vomit
urticaria
green
pretreat
diphenhydramin
hydrochlorid
dosag
mglkg
bodi
weight
prednisolon
rugkg
minut
transfus
may
reduc
reaction
tangner
reaction
becom
evid
transfus
infus
rate
slow
diphenhydramin
hydrochlorid
prednisolon
administ
intraven
febril
reaction
infus
blood
compon
occur
occasion
usual
mild
reaction
must
differenti
sepsi
caus
contamin
blood
compon
result
sever
shocklik
reaction
cotter
latter
occur
infus
stop
gram
stain
cultur
perform
transfus
blood
compon
support
care
antimicrobi
agent
given
septic
reaction
rare
asept
collect
proper
storag
administr
use
hypocalcemia
occur
result
rapid
administr
whole
blood
especi
plasma
cotter
sign
associ
hypocalcemia
includ
restless
vomit
tremor
seizur
cardiac
arrhythmia
hypocalcemia
like
occur
small
anim
sever
hepat
diseas
hypothermia
excess
citrat
anticoagul
present
plasma
administ
wintrob
et
ai
transfus
stop
temporarili
sign
hypocalcemia
usual
subsid
quickli
intraven
calcium
rare
need
cotter
rare
advers
reaction
includ
hypothermia
rapid
transfus
cold
blood
product
neurolog
sign
young
anim
hepatopathi
may
abl
rapidli
detoxifi
often
increas
ammonia
level
store
blood
circulatori
overload
acidosi
store
blood
may
ph
buchel
neonat
isoerythrolysi
immunogenet
disord
result
damag
kitten
red
blood
cell
matern
colostr
acquir
antibodi
cain
suzuki
gandolfi
hubler
et
ai
jonsson
et
al
mcclain
et
ai
overal
incid
neonat
isoerythrolysi
felin
popul
unknown
probabl
low
among
domest
shorthair
cat
may
respons
neonat
death
certain
purebr
catteri
parent
blood
type
giger
giger
neonat
isoerythrolysi
disord
occur
first
day
life
primarili
time
signific
amount
exogen
antibodi
gain
access
bodi
natur
situat
ingest
colostr
antibodi
direct
surfac
antigen
neonat
red
blood
cell
result
acceler
remov
destruct
circul
red
blood
cell
lead
anemia
secondari
problem
much
knowledg
felin
blood
group
transfus
medicin
gain
last
year
andrew
et
ai
buchel
giger
griotwenk
et
al
griotwenk
giger
blood
type
also
known
blood
group
speciesspecif
simpli
inherit
antigen
epitop
surfac
erythrocyt
see
tabl
giger
et
ai
antigen
produc
group
allel
gene
form
blood
group
system
individu
lack
blood
type
may
natur
occur
antibodi
may
gener
antibodi
exposur
antigen
sinc
earli
research
describ
two
major
felin
blood
type
known
b
blood
type
predominantli
found
type
auer
bell
eyquem
et
ai
giger
et
ai
cat
found
carri
antigen
erythrocyt
blood
type
ab
griotwenk
et
al
recent
survey
felin
blood
type
frequenc
unit
state
demonstr
low
frequenc
type
b
blood
domest
shorthair
cat
averag
reach
region
giger
et
al
b
siames
cat
relat
siames
tonkines
orient
shorthair
burmes
american
shorthair
cat
relat
domest
shorthair
type
blood
contrast
breed
persian
british
shorthair
abyssinian
birman
devon
rex
himalayan
somali
breed
type
b
frequenc
rang
tabl
subsequ
type
ab
cat
found
frequenc
consid
extrem
low
griotwenk
giger
griotwenk
et
al
felin
blood
type
b
red
blood
cell
phenotyp
due
action
two
differ
allel
autosom
gene
locu
complet
domin
b
therefor
cat
type
blood
genotyp
aa
ab
giger
et
al
rare
blood
type
ab
could
explain
action
third
allel
gene
locu
recess
domin
b
griotwenk
et
al
berlin
squar
root
frequenc
type
b
cat
persian
type
b
blood
gene
frequenc
b
nearli
equal
frequenc
british
shorthair
cat
frequenc
b
allel
higher
buchel
breed
practic
chanc
event
b
allel
frequenc
may
vari
greatli
catteri
purebr
line
part
world
test
type
b
cat
strong
natur
occur
alloantibodi
fatal
neonat
isoerythrolysi
occur
type
offspr
type
b
queen
bred
type
male
buchel
giger
mate
two
type
b
cat
produc
type
b
offspr
father
genotyp
aa
offspr
heterozyg
ab
risk
develop
neonat
isoerythrolysi
father
genotyp
ab
one
half
offspr
genotyp
ab
risk
neonat
isoerythrolysi
assum
equilibrium
hardyweinberg
law
proport
incompat
mate
estim
domest
shorthair
cat
mate
random
would
produc
litter
risk
hand
purebr
cat
persian
abyssinian
risk
incompat
mate
rang
buchel
type
b
cat
strong
hemagglutinin
hemolysin
serum
titer
rang
ratio
type
cell
wherea
type
cat
low
antib
antibodi
titer
typicallyonli
ratio
rare
reach
ratio
buchel
giger
antibodi
natur
occur
mean
antibodi
present
without
prior
sensit
transfus
pregnanc
leav
even
primipar
queen
risk
litter
neonat
isoerythrolysi
neonat
kitten
acquir
matern
antibodi
igg
class
via
colostrum
first
day
life
week
age
kitten
begin
produc
alloantibodi
alloantibodi
titer
reach
maximum
level
month
age
buchel
giger
contrast
speci
previou
transfus
pregnanc
requir
product
alloantibodi
cat
felin
placenta
endotheliochori
type
allow
small
insignific
passag
matern
antibodi
prevent
fetu
harm
kitten
type
ab
queen
type
b
colostr
antibodi
bind
lyse
red
blood
cell
newborn
buchel
hemolysi
may
occur
intravascularli
well
extravascularli
may
caus
anemia
chromoproteinur
nephropathi
organ
failur
well
dissemin
intravascular
coagul
giger
giger
clinic
sign
neonat
isoerythrolysi
relat
degre
rapid
onset
anemia
hemolysi
factor
determin
sever
hemolysi
identifi
larg
variat
clinic
si
may
observ
litter
suggestmg
differ
colostr
antibodi
uptak
respons
high
variabl
giger
giger
kitten
born
healthi
start
nursmg
vigor
result
colostrum
intak
ki
ten
start
show
clinic
sign
ill
within
hour
day
kitten
die
peracut
within
first
hour
without
show
clinic
sign
kitt
may
stp
nursi
g
first
day
life
fall
thrive
giger
giger
key
clinic
find
dark
redbrown
urin
indic
sever
hemoglobinuria
affect
kitten
may
develp
ict
anemia
continu
fade
die
first
week
life
accompani
sign
pallor
mucou
membran
refer
decreas
oxygen
lethargi
weak
tachypnea
tachycardia
collaps
death
secondari
problem
may
includ
metabol
acidosi
hypoglycemia
result
alter
nutrit
giger
giger
surviv
kitten
may
develop
tailtip
necrosi
slough
distal
part
tail
day
week
age
bridl
littlewood
giger
appear
possibl
coldreact
igm
antibodi
lead
hemagglutin
peripher
capillari
well
local
thrombu
format
ischem
necrosi
kitten
may
suffer
subclin
progress
continu
nurs
thrive
show
obviou
clinic
sign
may
exhibit
laboratori
abnorm
posit
coomb
test
mild
moder
anemia
hallmark
clinic
find
neonat
isoerythrolysi
hemoglobinuria
breeder
veterinarian
urg
collect
urin
manual
kitten
fade
order
determin
urin
color
presenc
hemoglobin
urin
may
obtain
gentli
stroke
perin
area
wet
warm
cloth
dri
soft
tissu
paper
mimick
queen
tongu
anogenit
reflex
hoskin
patholog
find
kitten
neonat
isoerythrolysi
may
vari
depend
time
death
urinari
bladder
may
fill
dark
redbrown
urin
precipit
hemoglobin
spleen
may
enlarg
bodi
may
appear
icter
mark
erythrophagocytosi
extramedullari
hematopoiesi
seen
liver
spleen
may
evid
acut
tubular
necrosi
kidney
system
effect
immunemedi
hemolysi
dissemin
intravascularoagulatlon
acut
renal
failur
anemia
like
caus
fatal
neonat
isoerythrolysi
kitten
show
clinic
sign
neonat
isoerythrolysi
immedi
remo
mother
soon
first
clinic
sign
recogn
order
tprt
vent
absorpt
matern
antibodi
kitten
kitten
durat
transfer
matern
antibodi
appear
approxim
hour
thu
kitten
risk
neonat
isoerythrolysi
need
remov
frome
queen
first
hour
hfe
avoid
incompat
foster
nurs
either
tubefeed
commerci
milk
replac
place
kitten
anoth
queen
type
blood
anemia
sever
worsen
replac
red
blood
cell
necessari
provid
oxygen
tissu
key
consider
regard
transfus
necess
identifi
red
blood
cell
compat
type
b
queen
serumcolostr
antibodi
antibodi
circul
type
kitten
transfus
type
cell
simpli
add
vulner
cell
milieu
destroy
matern
colostr
antibodi
compound
secondari
complic
ideal
blood
donor
would
queen
obvious
react
antibodi
sever
anem
kitten
may
benefit
transfus
wash
type
b
blood
first
day
life
may
administ
intraoss
transfus
giger
total
ml
queen
blood
collect
ethylenediamin
tetra
acet
acid
heparin
centrifug
rpm
minut
supernat
discard
blood
restor
previou
volum
normal
salin
solut
centrifug
supernat
discard
cell
dilut
equal
volum
normal
salin
solut
blood
transfus
via
spinal
needl
trochanter
fossa
femur
transfus
pack
cell
volum
may
declin
sever
day
result
continu
destruct
kitten
cell
shorten
lifespan
transfus
cell
kitten
start
form
antib
alloantibodi
soon
birth
therefor
kitten
requir
anoth
transfus
day
postpartum
one
consid
administ
wash
type
blood
addit
transfus
kitten
neonat
isoerythrolysi
receiv
intens
support
care
maintain
fluid
electrolyt
statu
nutrit
statu
normothermia
despit
remov
kitten
soon
first
clinic
sign
appear
mortal
result
neonat
isoerythrolysi
consider
neonat
isoerythrolysi
best
prevent
avoid
incompat
mate
type
b
queen
type
tom
blood
type
cat
catteri
recommend
ensur
blood
compat
simpl
inpractic
blood
type
card
test
avail
dm
laboratori
dart
mill
road
flemington
nj
placenta
blood
could
use
determin
kitten
blood
type
perform
crossmatch
serum
queen
type
b
queen
high
hemagglutinin
titer
coomb
reagent
requir
crossmatch
buchel
giger
sampl
protocol
major
crossmatch
felin
blood
type
might
includ
follow
step
